title: Optimal control of nausea and vomiting with a three-drug antiemetic regimen with aprepitant in metastatic pancreatic cancer patients treated with first-line modified FOLFIRINOX.
authors: Medical Oncology Unit, National Cancer Institute "Giovanni Paolo II", Viale Orazio Flacco, 65, 70124, Bari, Italy, n.silvestris@oncologico.bari.it.
authors: Nicola
authors: N
authors: Silvestris
authors: Anna Elisabetta
authors: AE
authors: Brunetti
authors: Marco
authors: M
authors: Russano
authors: Patrizia
authors: P
authors: Nardulli
mesh_terms: D000368:Aged; D000932:Antiemetics / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D000077608:Aprepitant; D001590:Benztropine / Q000008:administration & dosage; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003907:Dexamethasone / Q000008:administration & dosage; D004338:Drug Combinations; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000009:adverse effects; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage; D009025:Morpholines / Q000008:administration & dosage; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000009:adverse effects; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000932:Antiemetics; D004338:Drug Combinations; C071457:Metoclophen; D009025:Morpholines; D009944:Organoplatinum Compounds; D000077608:Aprepitant; D001590:Benztropine; D003907:Dexamethasone; D006220:Haloperidol; D008787:Metoclopramide; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin
references: Cancer. 2003 Jun 15;97(12):3090-8
references: 12784346
references: Cancer. 2005 Aug 15;104(4):864-8
references: 15973669
references: N Engl J Med. 2011 May 12;364(19):1817-25
references: 21561347